U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 1 of 1 results

BETADEX

MORE DETAILS

  JV039JZZ3A

Status:
Possibly Marketed Outside US
First approved in 1963
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
cholesterol transport involved in cholesterol storage
1
Conditions:
Pain
614
Niemann-Pick disease, type C1
1
Inflammation
102
Betadex is a nonreducing cyclic compound composed of seven alpha-(1-4) linked D-glucopyranosyl units. It is a pharmacologically inactive substance. Betadex is useful for stabilizing, solubilizing or delivering intermediate size molecules. Cyclodextri...
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966